title: Modulation of experimental herpes encephalitis-associated neurotoxicity through sulforaphane treatment.
abstract: Reactive oxygen species (ROS) produced by brain-infiltrating macrophages and neutrophils, as well as resident microglia, are pivotal to pathogen clearance during viral brain infection. However, unchecked free radical generation is also responsible for damage to and cytotoxicity of critical host tissue bystander to primary infection. These unwanted effects of excessive ROS are combated by local cellular production of antioxidant enzymes, including heme oxygenase-1 (HO-1) and glutathione peroxidase 1 (Gpx1). In this study, we showed that experimental murine herpes encephalitis triggered robust ROS production, as well as an opposing upregulation of the antioxidants HO-1 and Gpx1. This antioxidant response was insufficient to prevent tissue damage, neurotoxicity, and mortality associated with viral brain infection. Previous studies corroborate our data supporting astrocytes as the major antioxidant producer in brain cell cultures exposed to HSV-1 stimulated microglia. We hypothesized that stimulating opposing antioxidative responses in astrocytes, as well as neurons, would mitigate the effects of ROS-mediated neurotoxicity both in vitro and during viral brain infection in vivo. Here, we demonstrate that the addition of sulforaphane, a potent stimulator of antioxidant responses, enhanced HO-1 and Gpx1 expression in astrocytes through the activation of nuclear factor-E2-related factor 2 (Nrf2). Additionally, sulforaphane treatment was found to be effective in reducing neurotoxicity associated with HSV-stimulated microglial ROS production. Finally, intraperitoneal injections of sulforaphane into mice during active HSV infection reduced neuroinflammation via a decrease in brain-infiltrating leukocytes, macrophage- and neutrophil-produced ROS, and MHCII-positive, activated microglia. These data support a key role for astrocyte-produced antioxidants in modulating oxidative stress and neuronal damage in response to viral infection.
authors.affiliation: Center for Infectious Diseases and Microbiology Translational Research, Department of Medicine, University of Minnesota, Minneapolis, Minnesota, USA.
authors.forename: Scott J
authors.initials: SJ
authors.lastname: Schachtele
authors.forename: Shuxian
authors.initials: S
authors.lastname: Hu
authors.forename: James R
authors.initials: JR
authors.lastname: Lokensgard
mesh_terms: D000818:Animals; D000975:Antioxidants / Q000378:metabolism; D001253:Astrocytes / Q000187:drug effects / Q000378:metabolism / Q000473:pathology / Q000821:virology; D001921:Brain / Q000187:drug effects / Q000378:metabolism / Q000473:pathology / Q000821:virology; D020803:Encephalitis, Herpes Simplex / Q000201:enzymology / Q000276:immunology / Q000378:metabolism* / Q000473:pathology*; D005260:Female; D015971:Gene Expression Regulation, Enzymologic / Q000187:drug effects; D018259:Herpesvirus 1, Human / Q000472:pathogenicity / Q000502:physiology; D017879:Isothiocyanates; D008264:Macrophages / Q000187:drug effects / Q000276:immunology / Q000821:virology; D051379:Mice; D017628:Microglia / Q000187:drug effects / Q000378:metabolism / Q000473:pathology / Q000821:virology; D009474:Neurons / Q000187:drug effects* / Q000378:metabolism / Q000473:pathology / Q000821:virology*; D020556:Neutrophil Infiltration / Q000187:drug effects; D018384:Oxidative Stress / Q000187:drug effects; D012333:RNA, Messenger / Q000235:genetics / Q000378:metabolism; D017382:Reactive Oxygen Species / Q000378:metabolism; D013454:Sulfoxides; D013861:Thiocyanates / Q000494:pharmacology* / Q000627:therapeutic use*; D015533:Transcriptional Activation / Q000187:drug effects
chemical_list: D000975:Antioxidants; D017879:Isothiocyanates; D012333:RNA, Messenger; D017382:Reactive Oxygen Species; D013454:Sulfoxides; D013861:Thiocyanates; C016766:sulforaphane